Altre lingue Iqvia Holdings Inc.

Azioni

IQV

US46266C1053

Biotecnologia

Mercato chiuso - Nyse Altri mercati azionari 22:00:02 16/01/2026			Variaz. 5gg	Var. 1 gen.
237,68 ^USD	-1,49%		-1,95%	+5,44%

16/01	IQVIA HOLDINGS INC. : Baird è per il Buy	ZM
16/01	La pillola Wegovy di Novo fa un inizio promettente nella corsa al dimagrimento contro Lilly	RE

Altre lingue

16/01	Promising launch for Wegovy pill: Novo Nordisk shares surge in the US
16/01	Lancement prometteur de la pilule Wegovy : Novo Nordisk en forte hausse aux Etats-Unis
16/01	Novo's Wegovy pill makes encouraging start in weight-loss race vs Lilly
16/01	Novo's Wegovy pill tracks 3,071 prescriptions in first days of launch
15/01	Pharma sector doubles down on AI amid hopes of slashing costs, timelines
15/01	Zydus Lifesciences Limited Receives Final Approval from USFDA for Eltrombopag Tablets, 12.5 mg, 25 mg, 50 mg, and 75 mg
12/01	Alembic Pharmaceuticals Limited Receives USFDA Tentative Approval for Bosutinib Tablets, 400 Mg
08/01	Syneos Health, Inc. Appoints Simon Bartle as Chief Human Resources Officer, Effective January 8, 2026
30/12	M&S launches new food range for customers on weight-loss jabs
26/12	Formosa Pharmaceuticals, Inc. Receives Screening Acceptance Letter from SAHPRA for the Registration of App13007
22/12	Granules India Arm Gets US FDA's Tentative Nod for Generic Amphetamine Extended-Release Tablets
18/12	Alembic Pharmaceuticals Limited Announces USFDA Final Approval for Travoprost Ophthalmic Solution USP, 0.004% (Ionic Buffered Solution
18/12	Bavarian Nordic as Appoints Anne Louise Eberhard as New Chair of the Board of Directors
11/12	Glenmark Pharmaceuticals to Launch Leucovorin Calcium for Injection
10/12	Scienture and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli, the First FDA-Approved Ready-To-Use Oral Suspension of Losartan Potassium
10/12	IFyber Expands Analytical Capabilities with Launch of Advanced LC-MS Services
09/12	IQVIA Holdings Inc. Enter into an Amendment to Its Fifth Amended and Restated Credit Agreement
08/12	Halozyme Therapeutics, Inc. Announces Election of Jim Lang to Board of Directors, Effective December 4, 2025
02/12	Amneal Pharmaceuticals, Inc. Receives U.S. Fda Approval for Albuterol Sulfate Inhalation Aerosol
02/12	Iqvia announces strategic collaboration with AWS, naming AWS as preferred agentic cloud provider to power next-generation AI platform
02/12	IQVIA Names AWS as Preferred Agentic Cloud Partner for New AI Platform
02/12	IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform
01/12	Amneal Announces U.S. Fda Approval of Cyclosporine Ophthalmic Emulsion 0.05%
01/12	Lupin Gets US FDA Nod for Biosimilar Armlupeg
26/11	Shandong Boan Biotechnology Co., Ltd. Receives Marketing Approval for its Aflibercept Intravitreous Injection, Boyoujing

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Articoli MarketScreener Analisi MarketScreener Idee di trading

Altre lingue Iqvia Holdings Inc.

Azioni

IQV

US46266C1053

Biotecnologia

Altre lingue

Filtri